ViewRay Inc Stock
Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
ViewRay Inc Stock
Our community identified positive and negative aspects for ViewRay Inc stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the ViewRay Inc stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of ViewRay Inc in the next few years
Pros
?
B****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of ViewRay Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| ViewRay Inc | - | - | - | - | - | - | - |
| MicroVision Inc | 2.070% | -0.285% | -15.604% | -25.166% | -47.274% | -91.134% | 43.801% |
| Fonar Corp. New | -3.210% | -3.822% | -25.980% | 4.861% | -14.689% | 1.342% | -15.188% |
| Allscripts Healthcare | -6.760% | -6.757% | -5.479% | -38.938% | -25.405% | -47.727% | -19.062% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-15
From a high-level perspective, it appears that ViewRay (VRAY), a company in the Healthcare Equipment & Supplies industry, has been facing financial challenges over the years. A closer examination of the company's financial statements reveals some concerning trends, which will be discussed in detail below. However, it's worth mentioning that this industry has significant growth potential, and it must be taken into consideration in the analysis.
*Pros: *
Revenue Growth: ViewRay has experienced a growth in its total revenue year-over-year. From 2020 to 2022, the revenue increased from $57,017,000 to $102,206,000, which is a positive indication of the company's demand in the market.
Comments
ViewRay, Inc. (NASDAQ: VRAY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for VRAY provided by MarketBeat
ViewRay, Inc. (NASDAQ: VRAY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for VRAY provided by MarketBeat
ViewRay, Inc. (NASDAQ: VRAY) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for VRAY provided by MarketBeat